文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Update on the endorsement of CONSORT by high impact factor journals: a survey of journal "Instructions to Authors" in 2014.

作者信息

Shamseer Larissa, Hopewell Sally, Altman Douglas G, Moher David, Schulz Kenneth F

机构信息

Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.

School of Epidemiology, Public Health and Preventative Medicine, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.

出版信息

Trials. 2016 Jun 24;17(1):301. doi: 10.1186/s13063-016-1408-z.


DOI:10.1186/s13063-016-1408-z
PMID:27343072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4921029/
Abstract

BACKGROUND: The CONsolidated Standards Of Reporting Trials (CONSORT) Statement provides a minimum standard set of items to be reported in published clinical trials; it has received widespread recognition within the biomedical publishing community. This research aims to provide an update on the endorsement of CONSORT by high impact medical journals. METHODS: We performed a cross-sectional examination of the online "Instructions to Authors" of 168 high impact factor (2012) biomedical journals between July and December 2014. We assessed whether the text of the "Instructions to Authors" mentioned the CONSORT Statement and any CONSORT extensions, and we quantified the extent and nature of the journals' endorsements of these. These data were described by frequencies. We also determined whether journals mentioned trial registration and the International Committee of Medical Journal Editors (ICMJE; other than in regards to trial registration) and whether either of these was associated with CONSORT endorsement (relative risk and 95 % confidence interval). We compared our findings to the two previous iterations of this survey (in 2003 and 2007). We also identified the publishers of the included journals. RESULTS: Sixty-three percent (106/168) of the included journals mentioned CONSORT in their "Instructions to Authors." Forty-four endorsers (42 %) explicitly stated that authors "must" use CONSORT to prepare their trial manuscript, 38 % required an accompanying completed CONSORT checklist as a condition of submission, and 39 % explicitly requested the inclusion of a flow diagram with the submission. CONSORT extensions were endorsed by very few journals. One hundred and thirty journals (77 %) mentioned ICMJE, and 106 (63 %) mentioned trial registration. CONCLUSIONS: The endorsement of CONSORT by high impact journals has increased over time; however, specific instructions on how CONSORT should be used by authors are inconsistent across journals and publishers. Publishers and journals should encourage authors to use CONSORT and set clear expectations for authors about compliance with CONSORT.

摘要

相似文献

[1]
Update on the endorsement of CONSORT by high impact factor journals: a survey of journal "Instructions to Authors" in 2014.

Trials. 2016-6-24

[2]
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.

Cochrane Database Syst Rev. 2012-11-14

[3]
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'.

Trials. 2008-4-18

[4]
Endorsement of the CONSORT statement by high-impact medical journals in China: a survey of instructions for authors and published papers.

PLoS One. 2012-2-13

[5]
Endorsement of CONSORT by Chinese medical journals: a survey of "instruction to authors".

Chin J Integr Med. 2014-7

[6]
Guidance in author instructions of hematology and oncology journals: A cross sectional and longitudinal study.

PLoS One. 2017-4-28

[7]
Reporting Quality of Randomized Controlled Trials of Periodontal Diseases in Journal Abstracts-A Cross-sectional Survey and Bibliometric Analysis.

J Evid Based Dent Pract. 2017-9-21

[8]
Editorial policy and the reporting of randomized controlled trials: a survey of instructions for authors and assessment of trial reports in Indian medical journals (2004-05).

Natl Med J India. 2008

[9]
Editorial policies of pediatric journals: survey of instructions for authors.

Arch Pediatr Adolesc Med. 2010-3

[10]
Endorsement of ICMJE's Clinical Trial Registration Policy: a survey among journal editors.

Neth J Med. 2014-9

引用本文的文献

[1]
Data sharing statements for clinical trials: a cross-sectional survey of cardiology journals.

BMJ Open. 2025-7-22

[2]
Publication of data sharing statements in clinical trials by cardiovascular journals: a quantitative and qualitative analysis.

Sci Data. 2025-7-15

[3]
Editorial: Harmonization and Publication of the 2025 Updates of the CONSORT and SPIRIT Statements for Clinical Trials.

Med Sci Monit. 2025-6-1

[4]
CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.

BMJ. 2025-4-14

[5]
A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.

Psychedelic Med (New Rochelle). 2023-12-13

[6]
Data-Sharing Statements Requested from Clinical Trials by Public, Environmental, and Occupational Health Journals: Cross-Sectional Study.

J Med Internet Res. 2025-2-7

[7]
Describing randomization in trials included in systematic reviews in orthopaedic surgery.

Bone Jt Open. 2024-12-4

[8]
Text classification models for assessing the completeness of randomized controlled trial publications based on CONSORT reporting guidelines.

Sci Rep. 2024-9-17

[9]
Assessing the reporting quality of pediatric neuro-oncology protocols, abstracts, and trials: Adherence to the SPIRIT and CONSORT statements.

Neurooncol Pract. 2024-5-11

[10]
Reporting checklists in neuroimaging: promoting transparency, replicability, and reproducibility.

Neuropsychopharmacology. 2024-11

本文引用的文献

[1]
Transparency, reproducibility, and validation: raising the quality of reporting at the Journal of Neuro-Ophthalmology.

J Neuroophthalmol. 2015-3

[2]
[Recommendations for the conduct, reporting, editing and publication of scholarly work in medical journals].

Zhonghua Gan Zang Bing Za Zhi. 2014-10

[3]
Elevating the quality of disability and rehabilitation research: mandatory use of the reporting guidelines.

J Rehabil Med. 2014-5

[4]
Reducing waste from incomplete or unusable reports of biomedical research.

Lancet. 2014-1-8

[5]
Biomedical research: increasing value, reducing waste.

Lancet. 2014-1-11

[6]
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.

JAMA. 2013-2-27

[7]
Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

JAMA. 2012-12-26

[8]
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.

Cochrane Database Syst Rev. 2012-11-14

[9]
Consort 2010 statement: extension to cluster randomised trials.

BMJ. 2012-9-4

[10]
Getting the methods right--the foundation of patient-centered outcomes research.

N Engl J Med. 2012-8-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索